Stent Thrombosis No Longer an Issue With Newer-Generation Drug- Eluting Stents?

被引:15
|
作者
Stefanini, Giulio G. [1 ]
Windecker, Stephan [1 ]
机构
[1] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
关键词
Editorials; coronary artery disease; thrombosis; drug-eluting stents; everolimus; stents; BARE-METAL STENTS; ROUTINE CLINICAL-PRACTICE; BIODEGRADABLE POLYMER; CORONARY STENTS; OUTCOMES; METAANALYSIS; MULTICENTER; RESOLUTE;
D O I
10.1161/CIRCINTERVENTIONS.112.970970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:332 / 335
页数:4
相关论文
共 50 条
  • [31] Utility of the Syntax Score in Long-Term Outcomes after Newer-Generation Drug Eluting Stents in a Real-World
    Jinnouchi, Hiroyuki
    Kuramitsu, Shoichi
    Kobayashi, Yohei
    Hiromasa, Takashi
    Morinaga, Takashi
    Ando, Kenji
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (15) : B189 - B189
  • [32] Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease Meta-Analysis of Randomized Trials
    Bangalore, Sripal
    Toklu, Bora
    Patel, Neil
    Feit, Frederick
    Stone, Gregg W.
    CIRCULATION, 2018, 138 (20) : 2216 - 2226
  • [33] Prognostic implications of fractional flow reserve and coronary flow reserve after newer-generation drug-eluting stent implantation
    Ueno, H.
    Hoshino, M.
    Sugiyama, T.
    Kanaji, Y.
    Hada, M.
    Misawa, T.
    Nagamine, T.
    Nogami, K.
    Sayama, K.
    Matsuda, K.
    Yonetsu, T.
    Sasano, T.
    Kakuta, T.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1212 - 1212
  • [34] Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis
    Goel, Sachin
    El-Mallah, Wael
    Ige, Mobolaji
    Gupta, Supriya
    Tuzcu, E. Murat
    Ellis, Stephen
    Kapadia, Samir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B194 - B194
  • [35] Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough
    Baber, Usman
    Mehran, Roxana
    CARDIOLOGY, 2017, 138 (02) : 73 - 75
  • [36] Incidence and correlates of cumulative stent thrombosis with drug-eluting stents
    Kuchulakanti, PK
    Wolfram, R
    Torguson, R
    Bui, A
    Gevorkian, N
    Xue, ZY
    Satler, L
    Kent, K
    Lindsay, J
    Waksman, R
    CIRCULATION, 2005, 112 (17) : U749 - U749
  • [37] Stent Thrombosis Following Drug-Eluting Stents: Conflict of Generations
    Nammas, Wail
    JOURNAL OF INVASIVE CARDIOLOGY, 2013, 25 (09): : A28 - A28
  • [38] Stent thrombosis in randomized clinical trials of drug-eluting stents
    Mauri, Laura
    Hsieh, Wen-hua
    Massaro, Joseph M.
    Ho, Kalon K. L.
    D'Agostino, Ralph
    Cutlip, Donald E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10): : 1020 - 1029
  • [39] The relationship of the underlying lipidic plaque at the implanted newer-generation drug-eluting stents with future stent-related events: insights from the REASSURE-NIRS registry
    Murai, K.
    Kataoka, Y.
    Iwai, T.
    Sawada, K.
    Matama, H.
    Honda, S.
    Fujino, M.
    Yoneda, S.
    Takagi, K.
    Nishihira, K.
    Kanaya, T.
    Otsuka, F.
    Asaumi, Y.
    Tsujita, K.
    Noguchi, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2088 - 2088
  • [40] Long-Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer-Generation Drug-Eluting Stents
    van der Heijden, Liefke C.
    Kok, Marlies M.
    Zocca, Paolo
    Sen, Hanim
    Lowik, Marije M.
    Mariani, Silvia
    de Man, Frits H. A. F.
    Hartmann, Marc
    Stoel, Martin G.
    van Houwelingen, K. Gert
    Louwerenburg, J. W.
    Linssen, Gerard C. M.
    Doggen, Carine J. M.
    Grandjean, Jan G.
    von Birgelen, Clemens
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (03):